BridgeMD
New treatment option for Sentinel Lymph Node
Official title Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
ClinicalTrials.gov ID: NCT05927818
What this study is testing
- What it's testing
- The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90, women only
You may be able to join if
- Must have a suspicious adnexal mass for early stage ovarian cancer
- Must be medically and surgically fit enough to perform SLNB and complete the systematic lymphadenectomy.
You likely can't join if
- Ovarian mass with low probability for early stage ovarian cancer.
- Medical or surgical contraindications for surgical comprehensive staging.
- Metastatic cancers or double primary cancers (metachronous) of ovary
- Recurrent ovarian cancer
- Preoperative or intraoperative finding of advanced ovarian cancer (FİGO stage III and IV)
- Neoadjuvant ovarian cancer
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.